Veristat

Veristat is an innovative full-service, science-focused clinical research organization (CRO) with over 20 years of experience in supporting clinical trials and regulatory submissions for pharmaceutical, biotechnology, and medical device companies. Veristat offers comprehensive clinical development services, including biostatistics, statistical programming, medical writing, clinical monitoring, project management and data management, for a single study or an entire clinical program, as well as preparation of integrated summary documents and submission-ready CDISC data for regulatory filings. Due to Veristat’s unwavering commitment to scientific integrity, client focus and exceptional performance, long-lasting client relationships are our hallmark.

Patrick Flanagan

CEO and Chairman

2 past transactions

SQN Clinical

Acquisition in 2021
SQN Clinical is a specialist biometrics CROs in Europe and is the preferred clinical development partner for many pharmaceutical, biotechnology and animal healthcare companies in the UK, Europe and the rest of world.

Spero Oncology

Acquisition in 2016
Spero Oncology has joined Veristat, a US-based full service CRO with over 20 years of experience supporting pharmaceutical, biotechnology and medical device firms throughout the clinical trials and regulatory process, primarily in the United States and Canada. Together, we can make a difference for you by offering more services, in more countries, with more therapeutic and scientific expertise, to help you bring your novel therapies to market sooner.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.